CADENCE Trademark

Trademark Overview


On Wednesday, January 18, 2023, a trademark application was filed for CADENCE with the United States Patent and Trademark Office. The USPTO has given the CADENCE trademark a serial number of 79366831. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, April 30, 2024. This trademark is owned by MIRXES PTE. LTD.. The CADENCE trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:

Diagnostic preparations for medical and veterinary use or purposes; Medical diagnostic reactants for medical and veterinary diagnosis of diseases; diagnostic preparations for medical use for sale in kit form; diagnostic preparations for medical purposes; Biological indicators for medical diagnosis, namely, for detecting and diagnosing cancer; veterinary diagnostic reagents; Diagnostic reagents in kit form for conducting molecular biology assays for medical or veterinary purposes; Diagnostic reagents for medical or veterinary purposes; Diagnostic reagents for use in diagnostic tests for medical or veterinary purposes; pharmaceutical preparations for the treatment of disorders of the metabolic system; medical diagnostic reagents for testing of body fluids; Medical diagnostic assays that test for genetic anomalies for medical use; Diagnostic preparations for medical use; Biochemical preparations for diagnostic use for detecting and diagnosing cancer; Diagnostic preparations for medical pu...

Medical diagnostic services, namely, testing and analysis; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for the diagnosis of cancer; Medical services, namely, nucleic acid analysis for cancer diagnosis and prognosis; performing diagnosis of diseases; medical services for the diagnosis of conditions of the human body; genetic testing of animals for diagnostic or treatment purposes; medical laboratory services related to the treatment of patients; Medical advisory services in the field of oncological diseases; medical analysis for the diagnosis and treatment of persons; Medical services, namely, health risk assessment surveys; health-care services for treating and detecting cancer; genetic testing for medical purposes; Medical services, namely, nucleic acid screening for medical purposes; Medical analysis services for diagnosing and detecting cancer; medical screening; Health screening services in the field of cancer; all of the f...

Medical diagnostic apparatus for detecting and diagnosing cancer; Medical diagnostic instruments for analysis of body fluids; Biomedical testing apparatus for RNA, DNA and protein biomarkers testing; Medical diagnostics instruments in the nature of apparatus for testing RNA, DNA and protein biomarkers; medical instruments for infectious disease testing; Medical diagnostic testing apparatus for sale in kit form for testing RNA, DNA and protein biomarkers for diagnosing and detecting cancer; Medical diagnostic apparatus for testing RNA, DNA and protein biomarkers for diagnosing and detecting cancer; Diagnostic in-vitro diagnostic testing apparatus for medical use for diagnosing and detecting cancer; Medical diagnostic testing apparatus for use in molecular biology procedures, namely, testing DNA, RNA and protein biomarkers for diagnosing and detecting cancer; Diagnostic apparatus for blood tests for medical use; all of the foregoing related to cancer screening and diagnostic tests
cadence

General Information


Serial Number79366831
Word MarkCADENCE
Filing DateWednesday, January 18, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, April 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDiagnostic preparations for medical and veterinary use or purposes; Medical diagnostic reactants for medical and veterinary diagnosis of diseases; diagnostic preparations for medical use for sale in kit form; diagnostic preparations for medical purposes; Biological indicators for medical diagnosis, namely, for detecting and diagnosing cancer; veterinary diagnostic reagents; Diagnostic reagents in kit form for conducting molecular biology assays for medical or veterinary purposes; Diagnostic reagents for medical or veterinary purposes; Diagnostic reagents for use in diagnostic tests for medical or veterinary purposes; pharmaceutical preparations for the treatment of disorders of the metabolic system; medical diagnostic reagents for testing of body fluids; Medical diagnostic assays that test for genetic anomalies for medical use; Diagnostic preparations for medical use; Biochemical preparations for diagnostic use for detecting and diagnosing cancer; Diagnostic preparations for medical purposes; Diagnostic agents for pharmaceutical use in the medical field; Test reagents for medical diagnosis, namely, disease testing; diagnostic biomarker reagents for medical purposes; Chemical preparations for diagnostic medical purposes, namely, for detecting and diagnosing cancer; Chemical preparations for use in medical diagnostics, namely, nucleic acid analysis; Chemical preparations for detecting genetic and epigenetic predispositions for medical purposes; Medical diagnostic reagents for analysis of body fluids; Synthetic deoxyribonucleic acid and synthetic ribonucleic acid for medical use, namely, for detecting and diagnosing cancer; nucleic acid amplification reagents for medical use; all of the foregoing related to cancer screening and diagnostic tests
Goods and ServicesMedical diagnostic services, namely, testing and analysis; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for the diagnosis of cancer; Medical services, namely, nucleic acid analysis for cancer diagnosis and prognosis; performing diagnosis of diseases; medical services for the diagnosis of conditions of the human body; genetic testing of animals for diagnostic or treatment purposes; medical laboratory services related to the treatment of patients; Medical advisory services in the field of oncological diseases; medical analysis for the diagnosis and treatment of persons; Medical services, namely, health risk assessment surveys; health-care services for treating and detecting cancer; genetic testing for medical purposes; Medical services, namely, nucleic acid screening for medical purposes; Medical analysis services for diagnosing and detecting cancer; medical screening; Health screening services in the field of cancer; all of the foregoing related to cancer screening and diagnostic tests
Goods and ServicesMedical diagnostic apparatus for detecting and diagnosing cancer; Medical diagnostic instruments for analysis of body fluids; Biomedical testing apparatus for RNA, DNA and protein biomarkers testing; Medical diagnostics instruments in the nature of apparatus for testing RNA, DNA and protein biomarkers; medical instruments for infectious disease testing; Medical diagnostic testing apparatus for sale in kit form for testing RNA, DNA and protein biomarkers for diagnosing and detecting cancer; Medical diagnostic apparatus for testing RNA, DNA and protein biomarkers for diagnosing and detecting cancer; Diagnostic in-vitro diagnostic testing apparatus for medical use for diagnosing and detecting cancer; Medical diagnostic testing apparatus for use in molecular biology procedures, namely, testing DNA, RNA and protein biomarkers for diagnosing and detecting cancer; Diagnostic apparatus for blood tests for medical use; all of the foregoing related to cancer screening and diagnostic tests

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, April 10, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 10, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMIRXES PTE. LTD.
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressSG

Trademark Events


Event DateEvent Description
Thursday, April 6, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, April 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 14, 2023APPLICATION FILING RECEIPT MAILED
Tuesday, October 17, 2023ASSIGNED TO EXAMINER
Thursday, October 19, 2023NON-FINAL ACTION WRITTEN
Friday, October 20, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, October 27, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 27, 2023REFUSAL PROCESSED BY MPU
Wednesday, November 22, 2023REFUSAL PROCESSED BY IB
Friday, April 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 26, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, April 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 26, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, April 30, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, April 30, 2024LETTER OF SUSPENSION E-MAILED
Tuesday, April 30, 2024SUSPENSION LETTER WRITTEN
Wednesday, September 4, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, September 4, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, September 20, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB